Insights
-
News
Medacist Unveils RxDiversion Scorecard
CHESHIRE, Conn., April 5, 2021 /PRNewswire/ -- Medacist, the industry leader in drug diversion technology solutions, today launched the Medacist RxDivers...
-
News
Medacist Analytical Solutions Lead the Way in Fight Against Opioid Abuse
New growth and adoption of RxAuditor Investigate™ technology helps hospitals and healthcare institutions combat drug diversion CHESHIRE, Conn., Feb. 10,...
-
News
Medacist Implements COVID-19 Specific Therapeutic Analytics
Medacist recognizes that the current focus of the healthcare community has shifted towards combating the national healthcare crisis - COVID-19. In an effort...
-
News
Important Message about COVID-19
At this time, when the news is dominated by the Coronavirus (COVID-19) health emergency around the world, we wanted to personally reach out and let you know...
-
News
Medacist Returns to ASHP Midyear with Commercially Released RxAuditor Investigate – The First Offering of the Genesis Analytics Platform
CHESHIRE, CT, November 26, 2019 – Medacist, the pioneer and leader in drug diversion analytics, leads the industry once again with latest analytics platfo...
-
News
Medacist Announces Commercial Release of RxAuditor Investigate – The First Offering of the Genesis Analytics Platform
CHESHIRE, CT, October 9, 2019 – David J. Brzozowski, Sr, President & CEO, today announced the commercial release of RxAuditor Investigate. “I am ...